Tabar, Viviane

Tumor mutational load predicts survival after immunotherapy across multiple cancer types

Samstein, R. M., Lee, C.-H., Shoushtari, A. N., Hellmann, M. D., Shen, R., Janjigian, Y. Y., Barron, D. A., Zehir, A., Jordan, E. J., Omuro, A., et al. (2019) · Nature Genetics

Cancer Immunotherapy and BiomarkersCancer Genomics and Diagnostics

Cited by 4,071

Human ES cell-derived neural rosettes reveal a functionally distinct early neural stem cell stage

Elkabetz, Y., Panagiotakos, G., Al Shamy, G., Socci, N. D., Tabar, V., & Studer, L. (2008) · Genes & Development

Neurogenesis and neuroplasticity mechanismsPluripotent Stem Cells Research

Cited by 677

Use of human embryonic stem cells to model pediatric gliomas with H3.3K27M histone mutation

Funato, K., Major, T., Lewis, P. W., Allis, C. D., & Tabar, V. (2014) · Science

Glioma Diagnosis and TreatmentChromatin Remodeling and Cancer

Cited by 390

Gboxin is an oxidative phosphorylation inhibitor that targets glioblastoma

Shi, Y., Lim, S. K., Liang, Q., Iyer, S. V., Wang, H.-Y., Wang, Z., Xie, X., Sun, D., Chen, Y.-J., Tabar, V., et al. (2019) · Nature

Cancer, Hypoxia, and MetabolismMitochondrial Function and Pathology

Cited by 325

Stoichiometric and temporal requirements of Oct4, Sox2, Klf4, and c-Myc expression for efficient human iPSC induction and differentiation

Papapetrou, E. P., Tomishima, M. J., Chambers, S. M., Mica, Y., Reed, E., Menon, J., Tabar, V., Mo, Q., Studer, L., & Sadelain, M. (2009) · Proceedings of the National Academy of Sciences

Pluripotent Stem Cells ResearchDevelopmental Biology and Gene Regulation

Cited by 286

Phase I trial of hES cell-derived dopaminergic neurons for Parkinson’s disease

Tabar, V., Sarva, H., Lozano, A. M., Fasano, A., Kalia, S. K., Yu, K. K. H., Brennan, C., Ma, Y., Peng, S., Eidelberg, D., et al. (2025) · Nature

Parkinson's Disease Mechanisms and TreatmentsDeep Brain Stimulation and Movement Disorders

Cited by 181